99 related articles for article (PubMed ID: 5017422)
1. The conformational characteristics in solution of the cyclic hexapeptide Gly-Gly-D-Ala-D-Ala-Gly-Gly.
Tonelli AE; Brewster AI
J Am Chem Soc; 1972 Apr; 94(8):2851-4. PubMed ID: 5017422
[No Abstract] [Full Text] [Related]
2. The conformational characteristics in solution of the synthetic cyclic hexapeptide 5L-ala-D-ala.
Tonelli AE; Brewster AI
Biopolymers; 1973; 12(1):193-200. PubMed ID: 4687146
[No Abstract] [Full Text] [Related]
3. Proton magnetic resonance and conformational energy calculations of repeat peptides of tropoelastin. A permutation of the hexapeptide.
Renugopalakrishnan V; Khaled MA; Rapaka RS; Urry DW
Biochim Biophys Acta; 1978 Oct; 536(2):421-8. PubMed ID: 708779
[TBL] [Abstract][Full Text] [Related]
4. Solution conformations of two flexible cyclic pentapeptides: cyclo(Gly-Pro-D-Phe-Gly-Ala) and cyclo(Gly-Pro-D-Phe-Gly-Val).
Stroup AN; Rockwell AL; Gierasch LM
Biopolymers; 1992 Dec; 32(12):1713-25. PubMed ID: 1472654
[TBL] [Abstract][Full Text] [Related]
5. An approximate treatment of the conformational characteristics of the cyclic hexa-L-peptides (pro-ser-gly-pro-ser-gly) and (ser-pro-gly-ser-pro-gly).
Tonelli AE
J Am Chem Soc; 1972 Jan; 94(2):346-51. PubMed ID: 5060989
[No Abstract] [Full Text] [Related]
6. Conformational and ion binding properties of a cyclic octapeptide, cyclo (Ala-Leu-Pro-Gly)2.
Jois DS; Easwaran KR; Bednarek M; Blout ER
Biopolymers; 1992 Aug; 32(8):993-1001. PubMed ID: 1420982
[TBL] [Abstract][Full Text] [Related]
7. Harnessing D-amino acids for peptide motif designs. Synthesis and solution conformation of Boc-D-Glu-Ala-Gly-Lys-NHMe and Boc-L-Glu-Ala-Gly-Lys-NHMe.
Bobde V; Sasidhar YU; Durani S
Int J Pept Protein Res; 1994 Mar; 43(3):209-18. PubMed ID: 8005743
[TBL] [Abstract][Full Text] [Related]
8. Conformational interconversions of the cyclic hexapeptide cyclo(Pro-Gly) 3 .
Deber CM; Torchia DA; Wong SC; Blout ER
Proc Natl Acad Sci U S A; 1972 Jul; 69(7):1825-9. PubMed ID: 4505660
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive activity of some peptides related to cycloamanide A (CyA A) and to the active fragment of a peptide immunomodulator from ovine colostrum.
Bolewska-Pedyczak E; Wieczorek Z; Zimecki M; Siemion IZ
Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):297-301. PubMed ID: 8010869
[TBL] [Abstract][Full Text] [Related]
10. Combined use of molecular dynamics simulations and NMR to explore peptide bond isomerization and multiple intramolecular hydrogen-bonding possibilities in a cyclic pentapeptide, cyclo(Gly-Pro-D-Phe-Gly-Val).
Liu ZP; Gierasch LM
Biopolymers; 1992 Dec; 32(12):1727-39. PubMed ID: 1472655
[TBL] [Abstract][Full Text] [Related]
11. Effects of amino acid chirality and the chemical linker on the cell permeation characteristics of cyclic prodrugs of opioid peptides.
Liederer BM; Fuchs T; Vander Velde D; Siahaan TJ; Borchardt RT
J Med Chem; 2006 Feb; 49(4):1261-70. PubMed ID: 16480263
[TBL] [Abstract][Full Text] [Related]
12. Solution conformation of a cyclic neurokinin antagonist: a NMR and molecular dynamics study.
Zhang M; Quinn TP; Wong TC
Biopolymers; 1994 Sep; 34(9):1165-73. PubMed ID: 7948730
[TBL] [Abstract][Full Text] [Related]
13. Conformations of cyclic octapeptides. 4. Diastereomers of cyclo(Gly-Pro-Phe-Ala-Asn-Ala-Val-Ser).
Vishwanath CK; Go A; Parameswaran KN; Wang YS; Kopple KD
Int J Pept Protein Res; 1986 Oct; 28(4):428-36. PubMed ID: 3793373
[TBL] [Abstract][Full Text] [Related]
14. Conformational change of the triple-helical structure. II. Conformation of (Pro-Pro-Gly)n and (Pro-Pro-Gly)n (Ala-Pro-Gly)m(Pro-Pro-Pro-Gly)n in an aqueous solution.
Suto K; Noda H
Biopolymers; 1974 Nov; 13(11):2391-404. PubMed ID: 4429790
[No Abstract] [Full Text] [Related]
15. Cyclic pentapeptides as models for reverse turns: determination of the equilibrium distribution between type I and type II conformations of Pro-Asn and Pro-Ala beta-turns.
Stradley SJ; Rizo J; Bruch MD; Stroup AN; Gierasch LM
Biopolymers; 1990 Jan; 29(1):263-87. PubMed ID: 2328290
[TBL] [Abstract][Full Text] [Related]
16. Conformational-energy studies of tetrapeptide opiates. Candidate active and inactive conformations.
Loew G; Hashimoto G; Williamson L; Burt S; Anderson W
Mol Pharmacol; 1982 Nov; 22(3):667-77. PubMed ID: 7155126
[TBL] [Abstract][Full Text] [Related]
17. Conformations of psi [CH2NH] pseudopeptides. Cyclo[Gly-Pro psi [CH2NH]Gly-D-Phe-Pro]-TFA and cyclo[Gly-Pro psi [CH2NH]Gly-D-Phe-Pro].
Ma S; Spatola AF
Int J Pept Protein Res; 1993 Feb; 41(2):204-6. PubMed ID: 8458694
[TBL] [Abstract][Full Text] [Related]
18. High-resolution NMR studies of fibrinogen-like peptides in solution: structural basis for the bleeding disorder caused by a single mutation of Gly(12) to Val(12) in the A alpha chain of human fibrinogen Rouen.
Ni F; Konishi Y; Bullock LD; Rivetna MN; Scheraga HA
Biochemistry; 1989 Apr; 28(7):3106-19. PubMed ID: 2742828
[TBL] [Abstract][Full Text] [Related]
19. Conformational study of silk-like peptides containing the calcium-binding sequence from calbindin D9k using 13C CP/MAS NMR spectroscopy.
Asakura T; Hamada M; Nakazawa Y; Ha SW; Knight DP
Biomacromolecules; 2006 Feb; 7(2):627-34. PubMed ID: 16471940
[TBL] [Abstract][Full Text] [Related]
20. Conformational preference and potential templates of N-methylated cyclic pentaalanine peptides.
Chatterjee J; Mierke DF; Kessler H
Chemistry; 2008; 14(5):1508-17. PubMed ID: 18080261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
